Shortage reports
Actual shortage:
259 (8%)
Anticipated shortage:
1 (0%)
Avoided shortage:
10 (0%)
Resolved:
3057 (92%)
3327
Discontinuation Reports
To be discontinued:
2 (0%)
Discontinued:
411 (94%)
Reversed:
23 (5%)
436
485 (13%)
11 (4%)
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| TEVA-TRIAMTERENE/HCTZ | 50MG 25MG | TABLET | Resolved | 2020-06-25 | 2021-02-18 | 118957 |
| TEVA-TRIAMTERENE/HCTZ | 50MG 25MG | TABLET | Resolved | 2020-04-03 | 2020-05-14 | 110794 |
| TEVA-TRIMEL | 400MG 80MG | TABLET | Resolved | 2017-03-13 | 2020-02-13 | 1582 |
| TEVA-TRIMEL | 40MG 8MG | SUSPENSION | Actual shortage | 2017-03-13 | 2017-10-13 | 1591 |
| TEVA-TRIMEL | 40MG 8MG | SUSPENSION | Actual shortage | 2017-03-13 | 2017-10-13 | 1609 |
| TEVA-TRYPTOPHAN | 1G | TABLET | Resolved | 2024-01-11 | 2024-03-18 | 215713 |
| TEVA-TRYPTOPHAN | 1G | TABLET | Resolved | 2020-02-07 | 2020-03-26 | 105564 |
| TEVA-TRYPTOPHAN | 500MG | CAPSULE | Actual shortage | 2024-08-08 | 2024-08-08 | 234876 |
| TEVA-TRYPTOPHAN | 500MG | TABLET | Resolved | 2020-02-07 | 2020-03-26 | 105570 |
| TEVA-TRYPTOPHAN | 500MG | TABLET | Resolved | 2023-10-05 | 2024-03-18 | 206383 |
| TEVA-TRYPTOPHAN | 1G | TABLET | Resolved | 2021-06-17 | 2021-10-21 | 141119 |
| TEVA-TRYPTOPHAN | 500MG | CAPSULE | Resolved | 2021-09-23 | 2022-05-19 | 146098 |
| TEVA-VALACYCLOVIR | 500MG | TABLET | Actual shortage | 2026-03-26 | 2026-03-26 | 281506 |
| TEVA-VALACYCLOVIR | 500MG | TABLET | Resolved | 2024-02-15 | 2024-04-11 | 219674 |
| TEVA-VALACYCLOVIR | 500MG | TABLET | Resolved | 2019-10-31 | 2020-03-05 | 97605 |
| TEVA-VALACYCLOVIR | 500MG | TABLET | Resolved | 2024-04-18 | 2024-09-19 | 225489 |
| TEVA-VALGANCICLOVIR | 450MG | TABLET | Resolved | 2017-08-02 | 2018-03-13 | 18033 |
| TEVA-VALGANCICLOVIR | 450MG | TABLET | Resolved | 2023-04-27 | 2023-06-21 | 190683 |
| TEVA-VALGANCICLOVIR | 450MG | TABLET | Resolved | 2023-11-16 | 2024-03-28 | 210440 |
| TEVA-VALGANCICLOVIR | 450MG | TABLET | Resolved | 2023-09-19 | 2023-10-26 | 204769 |
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| TEVA-NAPROXEN | 375MG | TABLET | Discontinued | 2025-05-28 | 2025-05-28 | 258493 |
| TEVA-NAPROXEN SODIUM | 275MG | TABLET | Discontinued | 2025-05-28 | 2025-05-28 | 258522 |
| TEVA-NAPROXEN SODIUM DS | 550MG | TABLET | Discontinued | 2019-04-11 | 2019-04-11 | 81350 |
| TEVA-NORFLOXACIN | 400MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 65013 |
| TEVA-NYSTATIN | 100000UNIT | SUSPENSION | Discontinued | 2018-10-12 | 2018-10-12 | 63949 |
| TEVA-NYSTATIN | 100000UNIT | CREAM | Discontinued | 2020-07-10 | 2020-07-10 | 120056 |
| TEVA-NYSTATIN | 100000UNIT | SUSPENSION | Discontinued | 2018-10-12 | 2018-10-12 | 63946 |
| TEVA-OLMESARTAN | 40MG | TABLET | Discontinued | 2025-05-28 | 2025-05-28 | 258409 |
| TEVA-OLMESARTAN | 20MG | TABLET | Discontinued | 2025-05-28 | 2025-05-28 | 258412 |
| TEVA-OLMESARTAN / HCTZ | 12.5MG 20MG | TABLET | Discontinued | 2025-05-28 | 2025-05-28 | 258405 |
| TEVA-OLMESARTAN / HCTZ | 12.5MG 40MG | TABLET | Discontinued | 2025-05-28 | 2025-05-28 | 258400 |
| TEVA-OLMESARTAN / HCTZ | 25MG 40MG | TABLET | Discontinued | 2025-05-28 | 2025-05-28 | 258396 |
| TEVA-ONDANSETRON | 4MG | TABLET | Discontinued | 2025-05-28 | 2025-05-28 | 258774 |
| TEVA-OXYBUTYNIN | 5MG | TABLET | Discontinued | 2024-06-28 | 2024-06-29 | 231586 |
| TEVA-OXYBUTYNIN | 5MG | TABLET | Discontinued | 2024-10-11 | 2024-10-11 | 240078 |
| TEVA-PANTOPRAZOLE MAGNESIUM | 40MG | TABLET (DELAYED-RELEASE) | Discontinued | 2025-05-28 | 2025-05-28 | 258729 |
| TEVA-PANTOPRAZOLE MAGNESIUM | 40MG | TABLET (DELAYED-RELEASE) | Discontinued | 2021-02-12 | 2021-02-12 | 133891 |
| TEVA-PAROXETINE | 10MG | TABLET | Reversed | 2025-05-28 | 2025-06-04 | 258436 |
| TEVA-PAROXETINE | 20MG | TABLET | Reversed | 2025-05-28 | 2025-06-04 | 258430 |
| TEVA-PAROXETINE | 20MG | TABLET | Discontinued | 2019-12-09 | 2019-12-09 | 100547 |